Intravenous labetalol in the management of severe hypertension and hypertensive emergencies
- 1 May 1984
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 107 (5), 980-985
- https://doi.org/10.1016/0002-8703(84)90838-x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Endocrine and Metabolic Effects of Labetalol in ManJournal of Cardiovascular Pharmacology, 1981
- Combined Alpha- and Beta-Blockade With Labetalol in Post-Open Heart Surgery HypertensionChest, 1980
- Hypertensive response to labetalol in phaeochromocytoma.BMJ, 1980
- Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.BMJ, 1980
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 11. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experienceAmerican Heart Journal, 1980
- Management of hypertensive emergenciesCleveland Clinic Journal of Medicine, 1978
- LABETALOL IN HYPERTENSIVE EMERGENCIESThe Medical Journal of Australia, 1978
- INTRAVENOUS LABETALOL IN SEVERE HYPERTENSIONThe Lancet, 1975
- Pharmacology of AH 5158; a drug which blocks both α‐ and β‐adrenoceptorsBritish Journal of Pharmacology, 1972